Metraipolis › archive › dc_c65f4fbbdaf6
Medicinal chemistry perspectives on anticancer drug design based on clinical applications (2015-2025) — Europe PMC PMID:41041285
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41041285
- DOI
- 10.1039/d5ra05472a
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:06:40.866Z
- SHA-256 of the archived text
19f2bb48c78a5ab4a63c5c34085ba4cc0d159d3fd89d20940695f85a25e01024- Stable URL of this page
https://metraipolis.com/documento/dc_c65f4fbbdaf6
How to cite
Medicinal chemistry perspectives on anticancer drug design based on clinical applications (2015-2025) — Europe PMC PMID:41041285 — Europe PMC (en), https://europepmc.org/article/MED/41041285 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c65f4fbbdaf6 (Metraipolis archive dc_c65f4fbbdaf6, sha256 19f2bb48c78a5ab4a63c5c34085ba4cc0d159d3fd89d20940695f85a25e01024)
BibTeX
@misc{dcc65f4fbbdaf6,
title = {Medicinal chemistry perspectives on anticancer drug design based on clinical applications (2015-2025) — Europe PMC PMID:41041285},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41041285},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c65f4fbbdaf6; sha256 19f2bb48c78a5ab4a63c5c34085ba4cc0d159d3fd89d20940695f85a25e01024},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41041285. Agents can read the archived copy with the MCP tool read_document.